A novel complement activation-related molecular subtyping and its clinical value for ccRCC by Haotian Wei, Yajun Li, Shimiao Zhu, Changyi Quan

Get full text

Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study by Yupeng Cui, Yupeng Cui, Youyi Lu, Jitao Wu, Changyi Quan

Get full text

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration a... by Haotian Wei, Zhaochen Li, Yang Zhao, Shimiao Zhu, Simeng Wen, Changyi Quan

Get full text

Evaluation of bi-directional causal association between periodontitis and benign prostatic hyperplasia: epidemiological studies and two-sample mendelian randomization analysis by Haotian Wei, Guangjie Tian, Shendan Xu, Yaqi Du, Minting Li, Yonglan Wang, Jiayin Deng, Changyi Quan

Get full text

CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling by Jianpeng Yu, Tianyu Shen, Yang Li, Tangxi Hao, Long Yang, Hanlin Li, Xuan‐Mei Piao, Zheng Zhang, Shimiao Zhu, Changyi Quan, Wun‐Jae Kim, Yang Zhao, Yuanjie Niu, Zhiqun Shang

Get full text

HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer by Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu

Get full text